Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ASHLAND INC.ASH · Entity 4139 | Director | January 24, 2023 | January 26, 2023 |
| Celanese CorpCE · Entity 3922 | Director | March 10, 2026 | March 11, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ASHLAND INC.
Report date January 24, 2023 · Filed January 26, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 10,043 |
Reported balance
After 2023-01-24 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2023-01-24 · Grant · Acquired 1,365 · Balance 10,043 F1: Each Restricted Stock Unit represents a right to receive one (1) share of Ashland Common Stock. F2: Grant of stock settled Restricted Stock Units granted under Ashland Omnibus Incentive Plan and under Ashland Inc. Independent Director Deferred Compensation Program dated November 17, 2022. The Restricted Stock Units will vest one year after date of grant. One (1) Restricted Stock Units in the Ashland Inc. Independent Director Deferred Compensation Program is the equivalent of one (1) share of Ashland Common Stock. F3: Balance includes 8678 Restricted Stock Units mandatorily deferred pursuant to the Ashland's Deferred Compensation Plan for Non-Employee Directors. Balance also includes 32 additional Restricted Stock Units acquired in lieu of cash dividends paid on March 15, 2022, 31 additional Restricted Stock Units acquired in lieu of cash dividends paid on June 15, 2022, 32 additional Restricted Stock Units acquired in lieu of cash dividends paid on September 15, 2022 and 29 additional Restricted Stock Units acquired in lieu of cash dividends paid on December 15, 2022. |
Filing footnotes · ownership attribution and instrument terms
F1: Each Restricted Stock Unit represents a right to receive one (1) share of Ashland Common Stock.
F2: Grant of stock settled Restricted Stock Units granted under Ashland Omnibus Incentive Plan and under Ashland Inc. Independent Director Deferred Compensation Program dated November 17, 2022. The Restricted Stock Units will vest one year after date of grant. One (1) Restricted Stock Units in the Ashland Inc. Independent Director Deferred Compensation Program is the equivalent of one (1) share of Ashland Common Stock.
F3: Balance includes 8678 Restricted Stock Units mandatorily deferred pursuant to the Ashland's Deferred Compensation Plan for Non-Employee Directors. Balance also includes 32 additional Restricted Stock Units acquired in lieu of cash dividends paid on March 15, 2022, 31 additional Restricted Stock Units acquired in lieu of cash dividends paid on June 15, 2022, 32 additional Restricted Stock Units acquired in lieu of cash dividends paid on September 15, 2022 and 29 additional Restricted Stock Units acquired in lieu of cash dividends paid on December 15, 2022.
Celanese Corp
Report date March 10, 2026 · Filed March 11, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Phantom StockSEC Table II · derivative / convertible security | Direct | 10,241.119 |
Reported balance
After 2026-03-10 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-03-10 · Grant · Acquired 6.06 · Balance 10,241.119 F1: Each share of phantom stock represents the right to receive one share of Common Stock. F2: The reported phantom stock represents dividend equivalents on compensation deferred under the Company's 2008 Deferred Compensation Plan (the "Plan"). The shares of phantom stock become payable in shares of Common Stock, as provided in the Plan. |
Filing footnotes · ownership attribution and instrument terms
F1: Each share of phantom stock represents the right to receive one share of Common Stock.
F2: The reported phantom stock represents dividend equivalents on compensation deferred under the Company's 2008 Deferred Compensation Plan (the "Plan"). The shares of phantom stock become payable in shares of Common Stock, as provided in the Plan.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 02, 2018 Filed Mar 6, 2018 16:37 UTC | Celanese Corp CE · Entity 3922 | GrantPhantom Stock · Derivative | 25.558 | $104.63 | $2,674.13 |
DisclosureSEC source: 0001306830-18-000061 · wf-form4_152037220908570.xml · derivative · entry 1 IHLENFELD JAY V · CIK 0001205395 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,838.836 Underlying: Series A Common Stock · 25.558 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock represents the right to receive one share of Series A Common Stock. F2 · derivative.exercise_date: The reported phantom stock represents dividend equivalents on compensation deferred under the Company's 2008 Deferred Compensation Plan. The shares of phantom stock become payable in shares of Series A Common Stock, as provided in the Company's 2008 Deferred Compensation Plan, following the termination of the reporting person's service as a director of the Company. F2 · derivative.expiration_date: The reported phantom stock represents dividend equivalents on compensation deferred under the Company's 2008 Deferred Compensation Plan. The shares of phantom stock become payable in shares of Series A Common Stock, as provided in the Company's 2008 Deferred Compensation Plan, following the termination of the reporting person's service as a director of the Company. Read SEC document |
| January 25, 2018 Filed Jan 26, 2018 23:13 UTC | ASHLAND INC. ASH · Entity 4139 | GrantRestricted Stock Units · Derivative | 1,453 | $75.71 | $110,006.63 |
DisclosureSEC source: 0001127602-18-002685 · form4.xml · derivative · entry 1 IHLENFELD JAY V · CIK 0001205395 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,255 Underlying: Common Stock · 1,453 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit represents a right to receive one (1) share of Ashland Common Stock. F2 · derivative.exercise_date: Grant of deferred Restricted Stock Units pursuant to Ashland's Deferred Compensation Plan for Non-Employee Directors, and exempt under Rule 16b-3. The Restricted Stock Units will vest one year after date of grant. (One (1) Restricted Stock Unit in the Deferred Compensation Plan for Non-Employee Directors is the equivalent of one (1) share of Ashland Common Stock.) F2 · derivative.expiration_date: Grant of deferred Restricted Stock Units pursuant to Ashland's Deferred Compensation Plan for Non-Employee Directors, and exempt under Rule 16b-3. The Restricted Stock Units will vest one year after date of grant. (One (1) Restricted Stock Unit in the Deferred Compensation Plan for Non-Employee Directors is the equivalent of one (1) share of Ashland Common Stock.) F3 · balance_after: Balance includes 6 additional Restricted Stock Units acquired in lieu of cash dividends paid on December 15, 2017, pursuant to Ashland's Deferred Compensation Plan for Non-Employee Directors, exempt under Rule 16b-3. Read SEC document |
| November 09, 2017 Filed Nov 13, 2017 16:57 UTC | Celanese Corp CE · Entity 3922 | GrantPhantom Stock · Derivative | 25.373 | $104.93 | $2,662.39 |
DisclosureSEC source: 0001306830-17-000250 · wf-form4_151061023809499.xml · derivative · entry 1 IHLENFELD JAY V · CIK 0001205395 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,813.278 Underlying: Series A Common Stock · 25.373 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock represents the right to receive one share of Series A Common Stock. F2 · derivative.exercise_date: The reported phantom stock represents dividend equivalents on compensation deferred under the Company's 2008 Deferred Compensation Plan (the "Plan"). The shares of phantom stock become payable in shares of Series A Common Stock, as provided in the Plan, following the termination of the reporting person's service as a director of the Company. F2 · derivative.expiration_date: The reported phantom stock represents dividend equivalents on compensation deferred under the Company's 2008 Deferred Compensation Plan (the "Plan"). The shares of phantom stock become payable in shares of Series A Common Stock, as provided in the Plan, following the termination of the reporting person's service as a director of the Company. Read SEC document |
| August 07, 2017 Filed Aug 8, 2017 16:38 UTC | Celanese Corp CE · Entity 3922 | GrantPhantom Stock · Derivative | 26.828 | $98.78 | $2,650.07 |
DisclosureSEC source: 0001306830-17-000200 · wf-form4_150222466859771.xml · derivative · entry 1 IHLENFELD JAY V · CIK 0001205395 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,787.905 Underlying: Series A Common Stock · 26.828 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock represents the right to receive one share of Series A Common Stock. F2 · derivative.exercise_date: The reported phantom stock represents dividend equivalents on compensation deferred under the Company's 2008 Deferred Compensation Plan (the "Plan"). The shares of phantom stock become payable in shares of Series A Common Stock, as provided in the Plan, following the termination of the reporting person's service as a director of the Company. F2 · derivative.expiration_date: The reported phantom stock represents dividend equivalents on compensation deferred under the Company's 2008 Deferred Compensation Plan (the "Plan"). The shares of phantom stock become payable in shares of Series A Common Stock, as provided in the Plan, following the termination of the reporting person's service as a director of the Company. Read SEC document |
| June 05, 2017 Filed Jun 6, 2017 22:15 UTC | ASHLAND INC. ASH · Entity 4139 | GrantCommon Stock | 883 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-020718 · form4.xml · nonDerivative · entry 1 IHLENFELD JAY V · CIK 0001205395 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,883 F1 · price: Represents 883 shares of restricted stock granted pursuant to the adjustment described in this footnote. Ashland Global Holdings Inc. ("Ashland") distributed to its stockholders on May 12, 2017 (the "Distribution Date") 170,000,000 shares of Valvoline Inc. common stock as a pro rata dividend (the "Distribution"). Pursuant to the terms of the applicable equity compensation plan, the Reporting Person was entitled to receive the number of shares of restricted stock equal to the quotient of (x) the closing price of Ashland common stock on the Distribution Date and (y) the simple arithmetic average of the volume-weighted average price of Ashland common stock for each of the ten consecutive trading days immediately following the Distribution Date (such quotient, the "Equity Award Adjustment Ratio") for each such share of restricted stock. F2 · balance_after: Balance includes 1,883 shares of unvested Restricted Stock. Read SEC document |
| June 02, 2017 Filed Jun 6, 2017 22:15 UTC | ASHLAND INC. ASH · Entity 4139 | GrantRestricted Stock Units · Derivative | 839 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-020718 · form4.xml · derivative · entry 2 IHLENFELD JAY V · CIK 0001205395 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,787 Underlying: Common Stock · 839 shares Expires not disclosed F3 · derivative.exercise_price: Each Restricted Stock Unit represents a right to receive one (1) share of Ashland Common Stock. F5 · price: Pursuant to the terms of Ashland's Deferred Compensation Plan for Non-Employee Directors, the Reporting Person was entitled to receive the number of Restricted Stock Units equal to the Equity Award Adjustment Ratio for each such Restricted Stock Unit. Restricted Stock Units were acquired pursuant to Ashland's Deferred Compensation Plan for Non--Employee Directors. One (1) Restricted Stock Unit is the equivalent of one (1) share of common stock. F4 · derivative.exercise_date: The Restricted Stock Units are payable upon the same terms and conditions as were applicable to the Reporting Person's awards of Restricted Stock Units immediately prior to the Distribution. F4 · derivative.expiration_date: The Restricted Stock Units are payable upon the same terms and conditions as were applicable to the Reporting Person's awards of Restricted Stock Units immediately prior to the Distribution. F6 · balance_after: Balance includes 2 additional Restricted Stock Units acquired in lieu of cash dividends paid on March 15, 2017, pursuant to Ashland's Deferred Compensation Plan for Non-Employee Directors, exempt under Rule 16b-3 and converted as described above in footnote 5. Read SEC document |
| May 11, 2017 Filed May 12, 2017 16:09 UTC | Celanese Corp CE · Entity 3922 | GrantPhantom Stock · Derivative | 30.651 | $86.00 | $2,635.99 |
DisclosureSEC source: 0001306830-17-000156 · wf-form4_149461974299620.xml · derivative · entry 1 IHLENFELD JAY V · CIK 0001205395 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,761.077 Underlying: Series A Common Stock · 30.651 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock represents the right to receive one share of Series A Common Stock. F2 · derivative.exercise_date: The reported phantom stock represents dividend equivalents on compensation deferred under the Company's 2008 Deferred Compensation Plan (the "Plan"). The shares of phantom stock become payable in shares of Series A Common Stock, as provided in the Plan, following the termination of the reporting person's service as a director of the Company. F2 · derivative.expiration_date: The reported phantom stock represents dividend equivalents on compensation deferred under the Company's 2008 Deferred Compensation Plan (the "Plan"). The shares of phantom stock become payable in shares of Series A Common Stock, as provided in the Plan, following the termination of the reporting person's service as a director of the Company. Read SEC document |
| April 21, 2017 Filed Apr 24, 2017 16:36 UTC | Celanese Corp CE · Entity 3922 | GrantPhantom Stock · Derivative | 1,717 | $0.00 | $0.00 |
DisclosureSEC source: 0001306830-17-000142 · wf-form4_149306617241128.xml · derivative · entry 3 IHLENFELD JAY V · CIK 0001205395 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,730.426 Underlying: Series A Common Stock · 1,717 shares Expires not disclosed F3 · derivative.exercise_price: Each share of phantom stock represents the right to receive one share of Series A Common Stock. F4 · derivative.exercise_date: As provided in the 2008 Deferred Compensation Plan, on the earlier date previously elected by the reporting person to receive payment or the termination of the reporting person's service as a director of the Company, the reported phantom stock becomes payable in shares of Series A Common Stock subject to certain limitations. F4 · derivative.expiration_date: As provided in the 2008 Deferred Compensation Plan, on the earlier date previously elected by the reporting person to receive payment or the termination of the reporting person's service as a director of the Company, the reported phantom stock becomes payable in shares of Series A Common Stock subject to certain limitations. Read SEC document |
| April 21, 2017 Filed Apr 24, 2017 16:36 UTC | Celanese Corp CE · Entity 3922 | Disposition to issuerSeries A Common Stock | 1,717 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001306830-17-000142 · wf-form4_149306617241128.xml · nonDerivative · entry 2 IHLENFELD JAY V · CIK 0001205395 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,858 F2 · price: Upon vesting of 1,717 Restricted Stock Units granted to the reporting person on April 21, 2016, the reporting person deferred the receipt of 1,717 shares of Series A Common Stock and received instead 1,717 shares of phantom stock pursuant to the Company's 2008 Deferred Compensation Plan. As a result, the reporting person is reporting the disposition of 1,717 shares of Series A Common Stock in exchange for an equal number of shares of phantom stock. Read SEC document |
| April 20, 2017 Filed Apr 24, 2017 16:36 UTC | Celanese Corp CE · Entity 3922 | GrantSeries A Common Stock | 1,601 | $0.00 | $0.00 |
DisclosureSEC source: 0001306830-17-000142 · wf-form4_149306617241128.xml · nonDerivative · entry 1 IHLENFELD JAY V · CIK 0001205395 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,575 F1 · shares: Annual grant of restricted stock units pursuant to the Company's 2009 Global Incentive Plan, as Amended and Restated February 9, 2017. The restricted stock units vest in full on the one-year anniversary of the date of the grant. The reporting person has elected that upon vesting of the restricted stock units, receipt of the shares of Series A Common Stock be deferred under the Company's 2008 Deferred Compensation Plan; accordingly, upon vesting, the reporting person will instead receive an equal number of shares of phantom stock. As provided in the Company's 2008 Deferred Compensation Plan, the phantom stock becomes payable in shares of Series A Common Stock upon the earlier of the date previously elected by the reporting person to receive payment or the termination of the reporting person's service as a director of the Company. Read SEC document |
| March 03, 2017 Filed Mar 7, 2017 16:54 UTC | Celanese Corp CE · Entity 3922 | GrantPhantom Stock · Derivative | 15.992 | $89.99 | $1,439.12 |
DisclosureSEC source: 0001306830-17-000084 · wf-form4_148892367738453.xml · derivative · entry 1 IHLENFELD JAY V · CIK 0001205395 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,013.426 Underlying: Series A Common Stock · 15.992 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock represents the right to receive one share of Series A Common Stock. F2 · derivative.exercise_date: The reported phantom stock represents dividend equivalents on compensation deferred under the Company's 2008 Deferred Compensation Plan (the "Plan"). The shares of phantom stock become payable in shares of Series A Common Stock, as provided in the Plan, following the termination of the reporting person's service as a director of the Company. F2 · derivative.expiration_date: The reported phantom stock represents dividend equivalents on compensation deferred under the Company's 2008 Deferred Compensation Plan (the "Plan"). The shares of phantom stock become payable in shares of Series A Common Stock, as provided in the Plan, following the termination of the reporting person's service as a director of the Company. Read SEC document |
| January 26, 2017 Filed Jan 27, 2017 22:05 UTC | ASHLAND INC. ASH · Entity 4139 | GrantRestricted Stock Units · Derivative | 946 | $116.25 | $109,972.50 |
DisclosureSEC source: 0001127602-17-002684 · form4.xml · derivative · entry 2 IHLENFELD JAY V · CIK 0001205395 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 946 Underlying: Common Stock · 946 shares Expires not disclosed F2 · derivative.exercise_price: Each Restricted Stock Unit represents a right to receive one (1) share of Ashland Common Stock. F3 · derivative.exercise_date: Grant of deferred Restricted Stock Units pursuant to Ashland's Deferred Compensation Plan for Non-Employee Directors, and exempt under Rule 16b-3. The Restricted Stock Units will vest one year after date of grant. (One (1) Restricted Stock Unit in the Deferred Compensation Plan for Non-Employee Directors is the equivalent of one (1) share of Ashland Common Stock.) F3 · derivative.expiration_date: Grant of deferred Restricted Stock Units pursuant to Ashland's Deferred Compensation Plan for Non-Employee Directors, and exempt under Rule 16b-3. The Restricted Stock Units will vest one year after date of grant. (One (1) Restricted Stock Unit in the Deferred Compensation Plan for Non-Employee Directors is the equivalent of one (1) share of Ashland Common Stock.) Read SEC document |
| January 26, 2017 Filed Jan 27, 2017 22:05 UTC | ASHLAND INC. ASH · Entity 4139 | GrantCommon Stock | 1,000 | $116.25 | $116,250.00 |
DisclosureSEC source: 0001127602-17-002684 · form4.xml · nonDerivative · entry 1 IHLENFELD JAY V · CIK 0001205395 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000 F1 · kind: Grant of Restricted Common Stock, pursuant to Ashland's Incentive Plan as approved by the shareholders and exempt pursuant to Rule 16b-3. The shares in this grant will vest on the earlier of: (i) the Outside Director's Retirement, as defined in the Plan; (ii) the Outside Director's death or Disability, as defined in the Plan; or (iii) a 50% change in the beneficial ownership of Ashland Global Holdings Inc. as defined in Rule 13d-3 under the Securities Exchange Act of 1934. Read SEC document |
| November 10, 2016 Filed Nov 14, 2016 17:52 UTC | Celanese Corp CE · Entity 3922 | GrantPhantom Stock · Derivative | 18.775 | $76.29 | $1,432.34 |
DisclosureSEC source: 0001306830-16-000437 · wf-form4_147916392449059.xml · derivative · entry 1 IHLENFELD JAY V · CIK 0001205395 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,997.434 Underlying: Series A Common Stock · 18.775 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock represents the right to receive one share of Series A Common Stock. F2 · derivative.exercise_date: The reported phantom stock represents dividend equivalents on compensation deferred under the Company's 2008 Deferred Compensation Plan (the "Plan"). The shares of phantom stock become payable in shares of Series A Common Stock, as provided in the Plan, following the termination of the reporting person's service as a director of the Company. F2 · derivative.expiration_date: The reported phantom stock represents dividend equivalents on compensation deferred under the Company's 2008 Deferred Compensation Plan (the "Plan"). The shares of phantom stock become payable in shares of Series A Common Stock, as provided in the Plan, following the termination of the reporting person's service as a director of the Company. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.